» Articles » PMID: 17169173

Impact of Duration and Dose of Gonadotrophins on IVF Outcomes

Overview
Publisher Elsevier
Date 2006 Dec 16
PMID 17169173
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

In order to examine whether the duration of the follicular phase and changes in daily gonadotrophin dosages impact IVF outcome, a retrospective analysis of women who underwent oocyte retrieval and fresh embryo transfer was performed. Among the parameters assessed were the number of days of gonadotrophin stimulation, changes in the daily dosage of gonadotrophins, total ampoules of gonadotrophins, embryo implantation rates, clinical pregnancy rates and ongoing pregnancy rates. The number of days of gonadotrophin stimulation, as determined by standard follicular size criteria did not appear to influence IVF outcomes. There was no significant difference in pregnancy rates between women who were stimulated for <9 days, 10-11 days or >12 days. When grouped by amount of starting daily dose of gonadotrophins there was a significant inverse relationship between gonadotrophin requirements and pregnancy rates (P=0.02). The data suggest that the success of an IVF cycle depends on the ovaries' ability to develop follicles of the appropriate size, not the speed at which the ovaries perform this function.

Citing Articles

Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France".

Lehmann M, Pouly J, Barriere P, Boland L, Bean S, Jenkins J Eur J Obstet Gynecol Reprod Biol X. 2024; 23:100331.

PMID: 39220093 PMC: 11362636. DOI: 10.1016/j.eurox.2024.100331.


A hybrid artificial intelligence model leverages multi-centric clinical data to improve fetal heart rate pregnancy prediction across time-lapse systems.

Duval A, Nogueira D, Dissler N, Maskani Filali M, Delestro Matos F, Chansel-Debordeaux L Hum Reprod. 2023; 38(4):596-608.

PMID: 36763673 PMC: 10068266. DOI: 10.1093/humrep/dead023.


High initial FSH dosage reduces the number of available cleavage-stage embryos in a GnRH-antagonist protocol: Real-world data of 8,772 IVF cycles from China.

Luo X, Pei L, He Y, Li F, Han W, Xiong S Front Endocrinol (Lausanne). 2022; 13:986438.

PMID: 36325448 PMC: 9618590. DOI: 10.3389/fendo.2022.986438.


Association Between the Ratio of Ovarian Stimulation Duration to Original Follicular Phase Length and Fertilization Outcomes: A Novel Index to Optimise Clinical Trigger Time.

Zhao X, Zhang X, Wu S, Tan J Front Endocrinol (Lausanne). 2022; 13:862500.

PMID: 35957813 PMC: 9361069. DOI: 10.3389/fendo.2022.862500.


Stimulation Duration in Patients with Early Oocyte Maturation Triggering Criteria Does Not Impact IVF-ICSI Outcomes.

Stout S, Dabi Y, Dupont C, Selleret L, Touboul C, Chabbert-Buffet N J Clin Med. 2022; 11(9).

PMID: 35566454 PMC: 9102252. DOI: 10.3390/jcm11092330.